[MSB-73] Hypertrophic Obstructive Cardiomyopathy Management in the Pediatric Population: The Dilemma of Mitral Valve

Nazlı Melis Coşkun Yücel1, Ahmet Aydın1, Timuçin Sabuncu1

  • 1Department of Cardiovascular Surgery, Hacettepe University Faculty of Medicine, Ankara, Türkiye.

Insights

Mitral valve replacement combined with myectomy is more effective for pediatric hypertrophic cardiomyopathy (HOCM) patients, improving left ventricular cavity and reducing obstruction. This combined approach safely manages HOCM in children.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Hypertrophic cardiomyopathy (HOCM) in pediatric patients presents unique surgical challenges.
  • Left ventricular outflow tract (LVOT) obstruction and systolic anterior motion (SAM) are common complications.
  • Surgical intervention is necessary for symptomatic HOCM in children.

Purpose of the Study:

  • To evaluate the surgical experience with pediatric HOCM patients.
  • To compare outcomes of isolated myectomy versus combined myectomy and mitral valve replacement (MVR).
  • To assess the safety and efficacy of MVR in conjunction with myectomy for pediatric HOCM.

Main Methods:

  • Retrospective review of 10 pediatric HOCM patients undergoing surgery.
  • Procedures included isolated myectomy or myectomy with MVR.
  • Surgical approach involved aortotomy, left atriotomy, and apical ventriculotomy.

Main Results:

  • Eight patients underwent myectomy with MVR; two had isolated myectomy.
  • Isolated myectomy resulted in persistent SAM and higher LVOT gradients.
  • MVR in pediatric patients with narrow annuli was well-tolerated using low-profile valves.

Conclusions:

  • Combined MVR and myectomy is more effective in pediatric HOCM for LVOT gradient reduction and cavity enlargement.
  • This approach prevents SAM and offers greater cavity volume gain.
  • MVR combined with myectomy is a safe and effective surgical option for pediatric HOCM.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...